Measurement of leukotrienes urinary excretion in patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Mepolizumab decreases urinary excretion of LTE4 in severe asthma Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
The incidence of nasal polyps and corresponding LTE4 levels in severe asthma Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008
Changes in urinary LTE4 and acustic rhinomanometry following nasal challenge with ASA in ASA-tolerant and ASA-intolerant asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002
Urinary excretion of 8-iso-PGF2a-III in atopic and aspirin-sensitive asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Basement membrane thickness, eosinophilic inflammation and urinary LTE4 in patients with nasal polyps with or without bronchial asthma Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Beclometasone diproprionate prevents the allergen-induced urinary LTE4 early increase and the following late asthmatic response Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Urinary leukotriene E4 during specific bronchial challenge testing in occupational asthma Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006
Oxalate excretion in patients with allergic airway diseases Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
The leukotriene E4 excretion following nasal aspirin challenges in patients with rhinitis and asthma assessed by two distinct methods Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma Source: Eur Respir J 2004; 24: 226-230 Year: 2004
Urinary LTE4 is increased proportionally to asthma severity in steroid-treated patients vs healthy controls Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004
Endoscopic sinus surgery (ESS) attenuates aspirin-induced asthmatic reaction in patients with aspirin-intolerant asthma (AIA) Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
Gastro-oesophageal reflux (GER) and airway responsiveness to methacholine, physical exercise and capsaicin in bronchial asthma: effect of gastric acid secretion inhibition Source: Eur Respir J 2002; 20: Suppl. 38, 50s Year: 2002
Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
A combined bronchial, oral, and nasal challenge for aspirin-induced asthma Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004
Levels of exhaled nitric oxide (e-NO) are related to acid-induced hyper-responsiveness to MCh in non-atopic patients with gastro-esophageal reflux (GER) and persistent cough Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
Urinary cysteinyl leukotriene levels in acute asthma Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003
Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Source: Eur Respir J 2008; 32: 437-442 Year: 2008